Use of a panel of novel genes for differentiating breast cancer from non-breast tissues

Tumor Biology

Volumn 28, Issue 6, 2007, Pages 312-317

  O'Brien, Neil ^a,b   O'Donovan, Norma ^a   Foley, Deirdre ^b   Hill, Arnold D K ^b   McDermott, Enda ^b   O'Higgins, Niall ^b   Duffy, Michael J ^a,b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

B726P; Breast cancer; Mammaglobin; MUC1; SBEM

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MAMMAGLOBIN; MESSENGER RNA; MUCIN 1; PROTEIN BR 27 29; SMALL BREAST EPITHELIAL MUCIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MEASUREMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION;

EID: 42449106023     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000115527     Document Type: Article

References (24)

1. Hernandez J, Thompson IM: Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker. Cancer 2004;101:894-904.
2. Sherman SI: Thyroid carcinoma. Lancet 2003;361:501-511.
3. Duffy MJ: Serum Tumor markers in breast cancer: are they of clinical value? Clin Chem 2006;52:345-351.
4. Cheung K, Graves CRL, Robertson JFR: Tumour marker measurements in the diagnosis and monitoring of breast cancer. Cancer Treat Rev 2000;26:91-102.
5. Molina R, Barak V, van Dalen A, Duffy MJ, et al: Tumor markers in breast cancer: European Group of Tumor Markers (EGTM) recommendations. Tumor Biol 2005;26:281-293.
6. Zehenter BK, Carter D: Mammaglobin: a candidate diagnostic marker for breast cancer. Clin Biochem 2004;37:249-257.
7. Watson MA, Fleming TP: Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 1996;56:860-865.
8. Watson MA, Dintzis S, Darrow CM, et al: Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 1999;59:3028-3031.
9. Houghton RL, Dillon DC, Molesh DA, et al: Transcriptional complementarity in breast cancer: application to detection of circulating tumor cells. Mol Diagn 2001;6:79-91.
10. Jiang Y, Harlocker SL, Molesh DA, et al: Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays. Oncogene 2002;21:2270-2282.
11. O'Brien N, Maguire TM, O'Donovan N, Lynch N, et al: Mammaglobin A: a promising marker for breast cancer. Clin Chem 2002;48:1362-1364.
12. Colpitts TL, Billing-Medel P, Friedman P, et al: Mammaglobin is found in breast tissue as a complex with BU101. Biochemistry 2001;40:11048-11059.
13. Jager D, Karbach J, Pauligk C, et al: Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes. Cancer Immun 2005;5:11.
14. Jager D, Stockert E, Gure AO, et al: Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res 2001;61:2055-2061.
15. Miksicek RJ, Myal Y, Watson PH, et al: Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium. Cancer Res 2002;62:2736-2740.
16. Colpitts TL, Billing P, Granados E, et al: Identification and immunohistochemical characterization of a mucin-like glycoprotein expressed in early breast cancer. Tumor Biol 2002;23:263-278.
17. Yu C J, Shew JY, Shun CT, et al: Quantitative analysis of mRNA encoding MUC1, MUC2, and MUC5AC genes: a correlation between specific mucin gene expression and sialomucin expression in non-small cell lung cancer. Am J Respir Cell Mol Biol 1988;18:643-652.
18. Zehentner B, Dillon DC, Jiang Y, et al: Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes. Clin Chem 2002;48:1225-1231.
19. Bon GG, von Mensdorff-Pouilly S, Kenemans P, et al: Clinical and technical examination of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays. Clin Chem 1997;43:585-593.
20. Stieber P, Molina R, Chan DW, et al: Clinical evaluation of the Elecsys CA 15-3 test in breast cancer patients. Clin Lab 2003;49:15-24.
21. Reinholz MM, Nibbe A, Jonart LM, et al: Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer. Clin Cancer Res 2005;11:3722-3732.
22. Fanger GR, Houghton RL, Retter MW, et al: Detection of mammaglobin in the sera of patients with breast cancer. Tumor Biol 2002;23:212-221.
23. Bernstein JL, Godbold JH, Raptis G, et al: Identification of mammaglobin as a novel serum marker for breast cancer. Clin Cancer Res 2005;11:6528-6535.
24. Narayanan K, Jaramillo A, Benshoff ND, et al: Response of established human breast tumors to vaccination with mammaglobin-A cDNA. J Natl Cancer Inst2004;96:1388-1396.